{"id":"W2949752825","doi":"10.1097/01.hs9.0000561220.73976.40","title":"PF734 PATIENT PREFERENCES FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS OF A PATIENT SURVEY OF RAVULIZUMAB (ALXN1210) AND ECULIZUMAB","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Dosing; Clinical trial; Pediatrics; Internal medicine; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001569299,0.0002034358,0.0005533846,0.00003053929,0.0000577221,0.000004979168,0.0001690672,0.0001054787,0.0004368544],"category_scores_gemma":[0.00009680048,0.0001252879,0.0001446906,0.00009305623,0.0001777554,0.00003543917,0.00006314974,0.0000466851,0.000008734321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004189758,"about_ca_system_score_gemma":0.0001159768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001496556,"about_ca_topic_score_gemma":0.0005240756,"domain_scores_codex":[0.9983506,0.0002682808,0.0007816519,0.0002832025,0.00008614425,0.0002300788],"domain_scores_gemma":[0.9976741,0.0009471342,0.0006598057,0.0004546561,0.0002412069,0.00002307556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.055506,0.009003799,0.5594094,0.002731674,0.006906722,0.000006983844,0.02767286,0.0007191137,0.0986963,0.001582908,0.02218248,0.2155818],"study_design_scores_gemma":[0.02843431,0.02593203,0.4099069,0.000750097,0.0006087648,0.00004915177,0.008766051,0.00009678418,0.4964224,0.0003111694,0.02806414,0.0006581717],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869622,0.00914872,0.00001434565,0.00002979233,0.0003850297,0.001480696,0.001602724,0.000009772699,0.0003667435],"genre_scores_gemma":[0.999312,0.000115475,0.00007963227,0.000006013891,0.000007606867,0.00008152038,0.0001729848,0.00001141037,0.0002133258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3977261,"threshold_uncertainty_score":0.5109091,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02348369215930301,"score_gpt":0.2527574460414279,"score_spread":0.2292737538821248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}